EXANE DERIVATIVES MRK Holdings History

Number of Shares
64,879.00
Current Holdings Value*
$5.91 Mil
% of Portfolio
3.4%
Total Estimate Gain
$664,588.40
% of Total Estimate Gain
5.39%

EXANE DERIVATIVES's Merck & Co Inc Holding Summary

As of 2022-06-30, EXANE DERIVATIVES held 64,879.00 shares of Merck & Co Inc(MRK), totaling $5.91 Mil. This investment constitutes 3.4% of their stock portfolio, and EXANE DERIVATIVES now holds 0% of the outstanding Merck & Co Inc(MRK) stock.

The initial trade took place in 2014Q4. And since then EXANE DERIVATIVES has made 14 purchases of MRK, at an average price of $73.42, for a total of 167,993.00 shares. In addition, there have been 6 sales at an average price of $75.74 for 103,114.00 shares. Based on historical transaction data and MRK's current price of $79.96, EXANE DERIVATIVES's estimated gain on his MRK holdings is $664,588.40, reflecting a 5.39% gain to date.

EXANE DERIVATIVES MRK ($79.96) Holding Chart

EXANE DERIVATIVES MRK ($79.96) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1